Research location
Oak Forest
Illinois, United States
Advertisement
Research activity in Oak Forest
Illinois, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 12 trials and 12 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Oak Forest
12 linked trials · page 1 of 1A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic RetinopathyNCT07588100 · 2026-06-18 · 1 site observation
RECRUITING
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular EdemaNCT07592273 · 2026-06-01 · 1 site observation
RECRUITING
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)NCT05712720 · 2023-02-06 · 1 site observation
COMPLETED
Nesvategrast (OTT166) in Diabetic Retinopathy (DR)NCT05409235 · 2022-07-29 · 1 site observation
COMPLETED
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With and Without Diabetic RetinopathyNCT05296447 · 2022-04-04 · 1 site observation
ENROLLING_BY_INVITATION
A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.NCT05063734 · 2021-08-27 · 1 site observation
TERMINATED
A Study to Evaluate the Efficacy of Oral AKST4290 in Participants With Moderately Severe to Severe Diabetic Retinopathy (CAPRI)NCT05038020 · 2021-08-17 · 1 site observation
TERMINATED
RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)NCT04567550 · 2020-11-20 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate THR-149 Treatment for Diabetic Macular OedemaNCT04527107 · 2020-07-31 · 1 site observation
COMPLETED
Study of a High-Dose Aflibercept in Participants With Diabetic Eye DiseaseNCT04429503 · 2020-06-29 · 1 site observation
COMPLETED
A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic RetinopathyNCT04265261 · 2020-06-05 · 1 site observation
COMPLETED
Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular EdemaNCT03917472 · 2019-07-17 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.